Art

J-GLOBAL ID：202002212785045565   Reference number：20A2045279

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)

日本における現実世界設定の進行性非扁平上皮非小細胞肺癌患者における個別化第一選択療法のためのバイオマーカー試験:後ろ向き,多施設,観察研究(BRAVE研究)【JST・京大機械翻訳】

Author (9)： Shimizu Junichi (Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan) ,  Masago Katsuhiro (Department of Pathology and Molecular Diagnosis, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan) ,  Saito Haruhiro (Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi-ku, Yokohama, Japan) ,  Nishino Kazumi (Department of Thoracic Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan) ,  Kurata Takayasu (Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Osaka, Japan) ,  Itoh Yohji (Statistics Group, AstraZeneca, Kita-ku, Osaka, Japan) ,  Yoshimura Yoko (Medical Department, AstraZeneca, Kita-ku, Osaka, Japan) ,  Yabuki Yutaka (Medical Department, AstraZeneca, Kita-ku, Osaka, Japan) ,  Dosaka-Akita Hirotoshi (Department of Medical Oncology, Faculty of Medicine & Graduate School of Medicine, Hokkaido University, Sapporo, Japan)
Material： Therapeutic Advances in Medical Oncology
Volume： 12  Page： 1758835920904522  Publication year： 2020 
JST Material Number： W5408A  ISSN： 1758-8340  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Background: Molecular diagnost...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2045279&from=J-GLOBAL&jstjournalNo=W5408A") }}

Thesaurus term： Death ,  tumor ,  Mutation ,  monoclonal antibody ,  squamous cell carcinoma ,  *non-small cell lung cancer ,  EGF receptor ,  *biomarker ,  medical record ,  end point ,  EGFR-tyrosine kinase inhibitor ,  ALK Inhibitor ,  Programmed Cell Death 1 Receptor
Semi thesaurus term： 分子診断 ,  *非扁平上皮非小細胞肺癌 , 【Automatic Indexing@JST】

Author keywords (4)： anaplastic lymphoma kinase ,  epidermal growth factor receptor ,  programmed death-ligand 1 ,  ROS1

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Terms in the title (11)： 日本 ,  現実 ,  世界 ,  非扁平上皮非小細胞肺癌 ,  患者 ,  第一選択療法 ,  バイオマーカー ,  試験 ,  施設 ,  観察 ,  研究